Editorial : pegylated interferon combined with bulevirtide for chronic hepatitis delta-new life for an old timer?
| Errataetall: |
CommentOn: Aliment Pharmacol Ther. 2022 Jul;56(1):144-154. - PMID 35514008 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:56 |
|---|---|
| Enthalten in: |
Alimentary pharmacology & therapeutics - 56(2022), 5 vom: 02. Sept., Seite 912-913 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Riveiro-Barciela, Mar [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
3WJQ0SDW1A |
|---|
| Anmerkungen: |
Date Completed 09.08.2022 Date Revised 30.08.2022 published: Print CommentOn: Aliment Pharmacol Ther. 2022 Jul;56(1):144-154. - PMID 35514008 Citation Status MEDLINE |
|---|
| doi: |
10.1111/apt.17115 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM34454303X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM34454303X | ||
| 003 | DE-627 | ||
| 005 | 20231226023020.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/apt.17115 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1148.xml |
| 035 | |a (DE-627)NLM34454303X | ||
| 035 | |a (NLM)35934854 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Riveiro-Barciela, Mar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Editorial |b pegylated interferon combined with bulevirtide for chronic hepatitis delta-new life for an old timer? |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.08.2022 | ||
| 500 | |a Date Revised 30.08.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Aliment Pharmacol Ther. 2022 Jul;56(1):144-154. - PMID 35514008 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a Interferon-alpha |2 NLM | |
| 650 | 7 | |a Lipopeptides |2 NLM | |
| 650 | 7 | |a bulevirtide |2 NLM | |
| 650 | 7 | |a Polyethylene Glycols |2 NLM | |
| 650 | 7 | |a 3WJQ0SDW1A |2 NLM | |
| 700 | 1 | |a Palom, Adriana |e verfasserin |4 aut | |
| 700 | 1 | |a Buti, Maria |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Alimentary pharmacology & therapeutics |d 1992 |g 56(2022), 5 vom: 02. Sept., Seite 912-913 |w (DE-627)NLM012692506 |x 1365-2036 |7 nnns |
| 773 | 1 | 8 | |g volume:56 |g year:2022 |g number:5 |g day:02 |g month:09 |g pages:912-913 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/apt.17115 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 56 |j 2022 |e 5 |b 02 |c 09 |h 912-913 | ||